Showing results (51-60 of 3,651) with videos related to
Sort By:
Pageof 366
Experimental Neurology|December 1, 1986
Deep prepyriform cortex kindling and its relation to amygdala kindling in the ratK Morimoto, M Dragunow, G V GoddardEpilepsia|September 1, 1985
Is adenosine an endogenous anticonvulsant?M Dragunow, G V Goddard, R LavertyBrain Research|October 22, 1990
Haloperidol induces Fos and related molecules in intrastriatal grafts derived from fetal striatal primordiaM Dragunow, M Williams, R L FaullExperimental Neurology|June 1, 1987
Proconvulsant effects of theophylline on hippocampal afterdischargesM Dragunow, G V Goddard, R LavertyNeuroscience|June 1, 2000
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's diseaseM Glass, M Dragunow, R L FaullNeuroreport|November 14, 1997
Cycloheximide phase-shifts, but does not prevent, de novo Krox-24 protein expressionP E Hughes, T Alexi, M DragunowBrain Research|February 26, 1996
Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptorsM Glass, R L Faull, M DragunowGene Therapy|September 19, 2014
Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsyD Young, D M Fong, P A Lawlor, et al.Brain Research. Molecular Brain Research|July 1, 1991
Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compactaM Dragunow, J D Leah, R L FaullMolecular Neurobiology|January 1, 1991
The role of immediate early genes in the stabilization of long-term potentiationW C Abraham, M Dragunow, W P TatePageof 366